Super Levitra is a clinically validated, prescription-only pharmaceutical agent designed for the effective management of erectile dysfunction (ED). Combining two potent active ingredients—vardenafil and dapoxetine—this formulation not only addresses the physiological aspects of achieving and sustaining an erection but also incorporates benefits for premature ejaculation, offering a comprehensive therapeutic approach. It functions by enhancing blood flow to the penile tissues and modulating serotonin levels to improve control over ejaculation. Recommended for adult males diagnosed with ED, Super Levitra represents a significant advancement in dual-mechanism treatment, providing a reliable and efficient solution under appropriate medical supervision.

Features

• Contains vardenafil (a PDE5 inhibitor) and dapoxetine (a selective serotonin reuptake inhibitor)
• Available in 20mg/60mg strength per tablet
• Rapid onset of action, typically within 30–60 minutes
• Dual therapeutic effect: improves erection quality and delays ejaculation
• Long duration of efficacy, up to 4–6 hours
• Film-coated tablets for ease of administration

Benefits

• Achieve and maintain firm erections suitable for sexual activity
• Gain improved control over ejaculation timing
• Enhance sexual confidence and relationship satisfaction
• Experience a synergistic effect from two complementary mechanisms
• Benefit from a treatment that addresses both common male sexual dysfunctions concurrently
• Enjoy flexibility with on-demand dosing aligned to sexual activity

Common use

Super Levitra is primarily prescribed for the treatment of erectile dysfunction in adult men. It is also indicated for use in cases where premature ejaculation coexists with ED, providing a dual benefit. It is intended for use prior to anticipated sexual activity and is not recommended for daily administration unless specifically advised by a healthcare provider.

Dosage and direction

The standard recommended dose is one tablet (20mg vardenafil/60mg dapoxetine) taken orally with a full glass of water approximately 1–3 hours before sexual activity. Do not exceed one dose within a 24-hour period. The tablet may be taken with or without food, though high-fat meals may delay onset of action. Dosage adjustments may be necessary based on individual tolerance, efficacy, and concomitant medical conditions; always follow the prescribing physician’s instructions.

Precautions

• Not intended for use by women, children, or adolescents.
• Avoid alcohol consumption, as it may increase the risk of side effects such as dizziness or hypotension.
• Use with caution in patients with cardiovascular disease, severe renal or hepatic impairment.
• Sexual activity may pose a risk in patients with pre-existing heart conditions.
• Inform your healthcare provider of all medications and supplements currently being taken.
• This medication does not protect against sexually transmitted infections.

Contraindications

• Hypersensitivity to vardenafil, dapoxetine, or any excipients in the formulation.
• Patients taking nitrates or nitric oxide donors in any form.
• History of severe cardiovascular disorders, including unstable angina, heart failure, or recent myocardial infarction.
• Patients with a history of significant hepatic impairment.
• Concomitant use with strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir).
• Patients with hereditary problems of galactose intolerance, lactase deficiency, or glucose-galactose malabsorption.

Possible side effects

Common side effects may include headache, dizziness, flushing, nasal congestion, indigestion, and nausea. Less frequently, visual disturbances, palpitations, increased blood pressure, insomnia, and fatigue may occur. Rare but serious adverse effects include priapism (prolonged erection), syncope, severe hypotension, and serotonin syndrome. Seek immediate medical attention if you experience chest pain, shortness of breath, or an erection lasting more than 4 hours.

Drug interaction

Super Levitra may interact with:

• Nitrates and nitric oxide donors: risk of severe hypotension.
• Alpha-blockers: additive blood pressure-lowering effects.
• Other PDE5 inhibitors: increased risk of adverse reactions.
• Strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole): may increase plasma concentrations.
• Serotonergic drugs (e.g., SSRIs, SNRIs, tramadol): increased risk of serotonin syndrome.
• Antifungal agents, certain antibiotics, and HIV protease inhibitors.

Missed dose

Super Levitra is used on an as-needed basis; there is no scheduled dosing regimen. If you miss a planned dose before sexual activity, take it as soon as remembered unless it is too close to the time of activity. Do not double the dose to make up for a missed one.

Overdose

In case of suspected overdose, seek emergency medical attention immediately. Symptoms may include severe headache, dizziness, fainting, prolonged erection, irregular heartbeat, and severe hypotension. Supportive measures and symptomatic treatment are advised; priapism may require urgent medical intervention.

Storage

Store at room temperature (15–30°C), in the original container, away from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.

Disclaimer

This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new medication. Do not use this product without a valid prescription. The efficacy and safety profile described are based on clinical studies and prescribing information; individual experiences may vary.

Reviews

Clinical trials and post-marketing surveillance indicate high patient satisfaction with Super Levitra, particularly among those with comorbid erectile dysfunction and premature ejaculation. Users frequently report improved erectile function, enhanced ejaculatory control, and overall sexual satisfaction. Some note mild and transient side effects, which often diminish with continued use. Always discuss your experience and any concerns with your prescribing physician.